Web
Analytics
The news is by your side.

liver disease

Novartis, Pfizer join forces on potentially lucrative fatty liver disease

ZURICH/NEW YORK: Novartis and Pfizer are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics. The Swiss and US drugmakers announced on Monday that they will collaborate to develop combination therapies involving medicines they have been working on separately to treat nonalcoholic steatohepatitis, or NASH. Though hardly a household name, the progressive fatty liver disease with no approved treatments…

Red meat linked to liver disease, diabetes risk factor: study

NEW YORK: People who eat lots of processed and red meat are at increased risk of developing chronic liver disease and insulin resistance, a diabetes risk factor - especially if they like their steak well done, an Israeli study suggests. Researchers focused on what’s known as non-alcoholic fatty liver disease, which is associated with obesity and certain eating habits. While red and processed meat has long been linked to an increased risk of diabetes, certain cancers and heart disease, evidence to date has been mixed about…